Our Milestones
![](https://granulesindia.com/wp-content/uploads/2021/08/Group-5112.png)
Charting A Path Towards Success.
Regulatory Approvals
Revenue (Cr.), FY24
+
Number of Employees
+
Number of Products
Triton Laboratories was formed to produce Paracetamol API at our Bonthapally facility in Hyderabad.
![DSC-2 (6)](https://granulesindia.com/wp-content/uploads/2021/03/DSC-2-6.jpg)
1984
1990
Triton opened its second manufacturing facility at Jeedimetla to produce multiple APIs.
![DSC-2 (10)](https://granulesindia.com/wp-content/uploads/2021/03/DSC-2-10.jpg)
Granules India Private Limited was incorporated.
![](https://granulesindia.com/wp-content/uploads/2021/03/1991.jpg)
1991
1993
Granules established its first PFI facility at Jeedimetla.
![DSC-2 (7)](https://granulesindia.com/wp-content/uploads/2021/03/DSC-2-7.jpg)
Granules became a listed company, after having initial public offerings at the Hyderabad Stock Exchange.
![DSC-2 (8)](https://granulesindia.com/wp-content/uploads/2021/03/DSC-2-8.jpg)
1995
2001
Merger of Triton Laboratories with Granules
![2003](https://granulesindia.com/wp-content/uploads/2021/03/2003-1.jpg)
2003
Granules setsup a new large volume PFI facility in Gagillapur and a wholly owned subsidiary - Granules USA for marketing in the US.
![2003](https://granulesindia.com/wp-content/uploads/2021/03/2003-1.jpg)
A new Paracetamol plant was built in Bonthapally, Hyderabad.
![](https://granulesindia.com/wp-content/uploads/2021/03/2005.jpg)
2005
2008
Granules entered into the Finished Dosage segment.
![2008](https://granulesindia.com/wp-content/uploads/2021/03/2008-1.jpg)
Granules received US FDA approval for its first Abbreviated New Drug Application (ANDA).
![](https://granulesindia.com/wp-content/uploads/2021/04/fda.jpg)
2010
2013
Granules established an API R&D facility in Pragathi Nagar, Hyderabad further to strengthen its vision of being an integrated player.
![Pragati Nage 2013 Image](https://granulesindia.com/wp-content/uploads/2021/03/Pragati-Nage-2013-Image.jpg)
Granules acquired Auctus Pharma – An API Manufacturing Facility with regulatory approvals
![2014](https://granulesindia.com/wp-content/uploads/2021/03/2014-3.jpg)
2014
2014
Granules sets up a wholly owned subsidiary in the US; Granules Pharmaceutical to focus on formulation R&D to forward integrate its APIs.
![Pragati Nage 2013 Image](https://granulesindia.com/wp-content/uploads/2021/03/Pragati-Nage-2013-Image.jpg)
Granules entered the Over-the-Counter business in the US through its own label Granules Consumer Healthcare for OTC products to control the value chain.
![](https://granulesindia.com/wp-content/uploads/2021/03/2015.jpg)
2015
2016
Granules laid down the foundation for its Oncology OSD Plant in Visakhapatnam.
![2016](https://granulesindia.com/wp-content/uploads/2021/03/2016-1.jpg)
To nurture skill development Granules Launched Self Directed Team (SDT) program in Manufacturing Units.
![](https://granulesindia.com/wp-content/uploads/2021/04/2017.jpg)
2017
2018
Commenced LEAN SIX-Sigma Program at Granules to inculcate continuous improvement in all areas of business process performance.
![LEAN SIX-Sigma Program](https://granulesindia.com/wp-content/uploads/2021/04/LEAN-SIX-Sigma-Program.jpg)
Granules entered the front-end business for the sale of Rx Products in the US under the GPI Label.
![Group-5940](https://granulesindia.com/wp-content/uploads/2021/04/Group-5940-1.png)
2019
2020
Granules laid the foundation for the largest single manufacturing site for Multi-Unit Pellet system facility.
![](https://granulesindia.com/wp-content/uploads/2021/04/mups.jpg)
Set up GPAK, a 79,000 sq. ft. packaging facility with four packaging suites and a warehouse facility.
![](https://granulesindia.com/wp-content/uploads/2024/04/gpak-unit.jpg)
2023
Received approvals for 11 ANDAs.
![DSC-2 (1)](https://granulesindia.com/wp-content/uploads/2021/03/DSC-2-1.jpg)
2020
2019
Filed first oncology DMF & 7 other DMFs | 12 ANDAs & 3 MAs.
![](https://granulesindia.com/wp-content/uploads/2021/03/2019.jpg)